Viewing Study NCT01857869


Ignite Creation Date: 2025-12-24 @ 11:10 PM
Ignite Modification Date: 2026-02-02 @ 4:05 AM
Study NCT ID: NCT01857869
Status: COMPLETED
Last Update Posted: 2019-06-26
First Post: 2013-05-16
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy, Safety and Immunogenicity Study of GlaxoSmithKline(GSK) Biologicals' Candidate Malaria Vaccine 257049 in the Sporozoite Challenge Model in Healthy Malaria-naïve Adults
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malaria View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Efficacy View
None Sporozoite challenge model View
None Malaria View
None Immunogenicity View
None Malaria- naïve adults View
None Safety View